-
1
-
-
0037260139
-
Cancer statistics, 2003
-
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5-26
-
(2003)
CA Cancer J. Clin
, vol.53
, Issue.1
, pp. 5-26
-
-
Jemal, A.1
Murray, T.2
Samuels, A.3
Ghafoor, A.4
Ward, E.5
Thun, M.J.6
-
2
-
-
1842415957
-
Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1
-
Grönberg H, Xu J, South JR, et al. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res. 1997;57(21):4707-9.
-
(1997)
Cancer Res.
, vol.57
, Issue.21
, pp. 4707-4709
-
-
Grönberg, H.1
Xu, J.2
South, J.R.3
-
3
-
-
4444221866
-
Estimativas de incidência e mortalidade por câncer no Brasil
-
Brasil. Ministério da Saúde. Instituto Nacional do Câncer. Available from URL
-
Brasil. Ministério da Saúde. Instituto Nacional do Câncer. Estimativas de incidência e mortalidade por câ ncer no Brasil 2003. Available from URL: http://www.inca.gov.br/estimativas/2003/Accessed in 2004 (Apr 30).
-
(2003)
-
-
-
4
-
-
0020117514
-
Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas
-
Padhy LC, Shih C, Cowing D, Finkelstein R, Weinberg RA. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell. 1982; 28(4):865-71.
-
(1982)
Cell
, vol.28
, Issue.4
, pp. 865-871
-
-
Padhy, L.C.1
Shih, C.2
Cowing, D.3
Finkelstein, R.4
Weinberg, R.A.5
-
5
-
-
0027748098
-
Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma
-
Kuhn EJ, Kurnot RA, Sesterhenn IA, Chang EH, Moul JW. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. J Urol. 1993;150(5 Pt 1):1427-33.
-
(1993)
J. Urol.
, vol.150
, Issue.5 PART 1
, pp. 1427-1433
-
-
Kuhn, E.J.1
Kurnot, R.A.2
Sesterhenn, I.A.3
Chang, E.H.4
Moul, J.W.5
-
6
-
-
0030046426
-
Overexpression of her-2/neu in human prostate cancer and benign hyperplasia
-
Gu K, Mes-Masson AM, Gauthier J, Saad F. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia. Cancer Lett. 1996;99(2):185-9.
-
(1996)
Cancer Lett.
, vol.99
, Issue.2
, pp. 185-189
-
-
Gu, K.1
Mes-Masson, A.M.2
Gauthier, J.3
Saad, F.4
-
7
-
-
0033010121
-
New pieces to the prostate cancer puzzle
-
Visakorpi T. New pieces to the prostate cancer puzzle. Nat Med. 1999;5(3):264-5.
-
(1999)
Nat. Med.
, vol.5
, Issue.3
, pp. 264-265
-
-
Visakorpi, T.1
-
8
-
-
0031012825
-
Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer
-
McDonnell TJ, Navone NM, Troncoso P, et al. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. J Urol. 1997;157(2):569-74.
-
(1997)
J. Urol.
, vol.157
, Issue.2
, pp. 569-574
-
-
McDonnell, T.J.1
Navone, N.M.2
Troncoso, P.3
-
9
-
-
0028814121
-
Relationships beaween proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells
-
Sinha BK, Yamazaki H, Eliot HM, Schneider E, Borner MM, O'Connor PM. Relationships beaween proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochim Biophys Acta. 1995;1270(1):12-8.
-
(1995)
Biochim. Biophys. Acta
, vol.1270
, Issue.1
, pp. 12-18
-
-
Sinha, B.K.1
Yamazaki, H.2
Eliot, H.M.3
Schneider, E.4
Borner, M.M.5
O'Connor, P.M.6
-
10
-
-
0026609019
-
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation
-
Bodner SM, Minna JD, Jensen SM, et al. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene. 1992;7(4):743-9.
-
(1992)
Oncogene
, vol.7
, Issue.4
, pp. 743-749
-
-
Bodner, S.M.1
Minna, J.D.2
Jensen, S.M.3
-
11
-
-
0027331484
-
p53 protein accumulation and gene mutation in the progression of human prostate carcinoma
-
Navone NM, Troncoso P, Pisters LL, et al. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst. 1993;85(20):1657-69.
-
(1993)
J. Natl. Cancer Inst.
, vol.85
, Issue.20
, pp. 1657-1669
-
-
Navone, N.M.1
Troncoso, P.2
Pisters, L.L.3
-
12
-
-
17044460982
-
Prognostic significance of p53 nuclear accumulation in localization prostate cancer treated with radical prostatectomy
-
Quinn DI, Henshall SM, Head DR, et al. Prognostic significance of p53 nuclear accumulation in localization prostate cancer treated with radical prostatectomy. Cancer Res. 2000;60(6):1585-94.
-
(2000)
Cancer Res.
, vol.60
, Issue.6
, pp. 1585-1594
-
-
Quinn, D.I.1
Henshall, S.M.2
Head, D.R.3
-
13
-
-
17144463251
-
Abnormal expression of MDM2 in prostate carcinoma
-
Leite KR, Franco MF, Srougi M, et al. Abnormal expression of MDM2 in prostate carcinoma. Mod Pathol. 2001;14(5):428-36.
-
(2001)
Mod. Pathol.
, vol.14
, Issue.5
, pp. 428-436
-
-
Leite, K.R.1
Franco, M.F.2
Srougi, M.3
-
15
-
-
0033089987
-
Analysis of p53 expression and proliferative assessment using PCNA in localized prostate carcinoma
-
Leite KR, Srougi M, Nesralhah LJ, Camara-Lopes LH. Analysis of p53 expression and proliferative assessment using PCNA in localized prostate carcinoma. Braz J Med Biol Res. 1999;32(3):283-8.
-
(1999)
Braz. J. Med. Biol. Res.
, vol.32
, Issue.3
, pp. 283-288
-
-
Leite, K.R.1
Srougi, M.2
Nesralhah, L.J.3
Camara-Lopes, L.H.4
-
16
-
-
0026781395
-
Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma
-
Visakorpi T. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol. 1992;168(1):7-13.
-
(1992)
J. Pathol.
, vol.168
, Issue.1
, pp. 7-13
-
-
Visakorpi, T.1
-
17
-
-
0001916430
-
Histologic grading and clinical stating of prostatic carcinoma
-
The Veterans Administration Cooperative Urological Research Group: Tannenbaum M, editor. Philadelphia: Lea and Febiger
-
Gleason DF. The Veterans Administration Cooperative Urological Research Group: Histologic grading and clinical stating of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology: the prostate. Philadelphia: Lea and Febiger; 1977. p.171-97.
-
(1977)
Urologic Pathology: The Prostate
, pp. 171-197
-
-
Gleason, D.F.1
-
18
-
-
0025126776
-
Intraglandular tumor extent and prognosis in prostatic carcinoma: Application of a grid method to prostatectomy specimens
-
Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol. 1990;21(8):799-804.
-
(1990)
Hum. Pathol.
, vol.21
, Issue.8
, pp. 799-804
-
-
Humphrey, P.A.1
Vollmer, R.T.2
-
19
-
-
0026444924
-
The TNM classification of prostate cancer
-
Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl. 1992;4:129-38.
-
(1992)
Prostate Suppl.
, vol.4
, pp. 129-138
-
-
Schröder, F.H.1
Hermanek, P.2
Denis, L.3
Fair, W.R.4
Gospodarowicz, M.K.5
Pavone-Macaluso, M.6
-
20
-
-
0001829168
-
Antigen unmasking on formalin-fixed paraffin-embedded tissues using microwaves: A review
-
Cattoretti G, Suurmeijer AJH. Antigen unmasking on formalin-fixed paraffin-embedded tissues using microwaves: a review. Adv Anat Pathol. 1995;2(1):2-9.
-
(1995)
Adv. Anat. Pathol.
, vol.2
, Issue.1
, pp. 2-9
-
-
Cattoretti, G.1
Suurmeijer, A.J.H.2
-
21
-
-
0000428461
-
Immunocytomicroscopy: A diagnostic tool for surgical pathologist Major
-
2nd Edition. Philadelphia,: WB Saunders Company
-
Taylor CR, Cote RJ. Immunocytomicroscopy: a diagnostic tool for surgical pathologist. In: Major Problems in pathology, Vol 19, 2nd Edition. Philadelphia,: WB Saunders Company; 1994. p.421-3.
-
(1994)
Problems in Pathology
, vol.19
, pp. 421-423
-
-
Taylor, C.R.1
Cote, R.J.2
-
22
-
-
0033591010
-
Biological determinants of cancer progression in men with prostate cancer
-
Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnston IM. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281(15):1395-400
-
(1999)
JAMA
, vol.281
, Issue.15
, pp. 1395-1400
-
-
Stamey, T.A.1
McNeal, J.E.2
Yemoto, C.M.3
Sigal, B.M.4
Johnston, I.M.5
-
23
-
-
0034079667
-
The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: A proposal to modify the Gleason grading system
-
Pan CC, Potter SR, Partin AW, Epstein JI. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol. 2000;24(4):563-9.
-
(2000)
Am. J. Surg. Pathol.
, vol.24
, Issue.4
, pp. 563-569
-
-
Pan, C.C.1
Potter, S.R.2
Partin, A.W.3
Epstein, J.I.4
-
24
-
-
0028566502
-
Five year follow-up after radical prostatectomy for localized prostate cancer - A study of the impact of different tumor variables on progression
-
Norberg M, Holmberg L, Wheeler T, Magnusson A. Five year follow-up after radical prostatectomy for localized prostate cancer - a study of the impact of different tumor variables on progression. Scand J Urol Nephrol. 1994;28(4):391-9.
-
(1994)
Scand. J. Urol. Nephrol.
, vol.28
, Issue.4
, pp. 391-399
-
-
Norberg, M.1
Holmberg, L.2
Wheeler, T.3
Magnusson, A.4
-
25
-
-
0026651717
-
Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation
-
Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T, Isola J. Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst. 1992;84(11):883-7.
-
(1992)
J. Natl Cancer Inst.
, vol.84
, Issue.11
, pp. 883-887
-
-
Visakorpi, T.1
Kallioniemi, O.P.2
Heikkinen, A.3
Koivula, T.4
Isola, J.5
-
26
-
-
0033151791
-
p53 alteration in regional lymph node metastases from prostate carcinoma: A marker for progression?
-
Cheng L, Liebovich BC, Bergstralh EJ, et al. p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression? Cancer. 1999;85(11):2455-9.
-
(1999)
Cancer
, vol.85
, Issue.11
, pp. 2455-2459
-
-
Cheng, L.1
Liebovich, B.C.2
Bergstralh, E.J.3
-
27
-
-
0030829938
-
Combined analysis with Bcl-2 and P53 immunostaining predicts poorer prognosis in prostatic carcinoma
-
Matsushima H, Kitamura T, Goto T, Hosaka Y, Homma Y, Kawabe K. Combined analysis with Bcl-2 and P53 immunostaining predicts poorer prognosis in prostatic carcinoma. J Urol. 1997;158(6):2278-83.
-
(1997)
J. Urol.
, vol.158
, Issue.6
, pp. 2278-2283
-
-
Matsushima, H.1
Kitamura, T.2
Goto, T.3
Hosaka, Y.4
Homma, Y.5
Kawabe, K.6
-
28
-
-
0035167070
-
HER-2/neu in breast cancer: Interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization
-
Thomson TA, Hayes MM, Spinelli JJ, et al. HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod Pathol. 2000;14(11):1079-86.
-
(2000)
Mod. Pathol.
, vol.14
, Issue.11
, pp. 1079-1086
-
-
Thomson, T.A.1
Hayes, M.M.2
Spinelli, J.J.3
-
29
-
-
0026531267
-
p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate
-
Mellon K, Thompson S, Charlton RG, et al. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol. 1992;147(2):496-9.
-
(1992)
J. Urol.
, vol.147
, Issue.2
, pp. 496-499
-
-
Mellon, K.1
Thompson, S.2
Charlton, R.G.3
-
30
-
-
0031740741
-
An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer preliminary results and therapeutic implications
-
Mydlo JH, Kral JG, Volpe M, Axotis C, Macchia RJ, Pertschuk LP. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer preliminary results and therapeutic implications. Eur Urol. 1998;34(5):426-32.
-
(1998)
Eur. Urol.
, vol.34
, Issue.5
, pp. 426-432
-
-
Mydlo, J.H.1
Kral, J.G.2
Volpe, M.3
Axotis, C.4
Macchia, R.J.5
Pertschuk, L.P.6
-
31
-
-
0031012825
-
Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer
-
McDonnell TJ, Navone NM, Troncoso P, et al. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. J Urol. 1997;157(2):569-74.
-
(1997)
J. Urol.
, vol.157
, Issue.2
, pp. 569-574
-
-
McDonnell, T.J.1
Navone, N.M.2
Troncoso, P.3
-
32
-
-
0031667532
-
Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma
-
Keshgegian AA, Johnston E, Cnaan A. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma. Am J Clin Pathol. 1998;110(4):443-9.
-
(1998)
Am. J. Clin. Pathol.
, vol.110
, Issue.4
, pp. 443-449
-
-
Keshgegian, A.A.1
Johnston, E.2
Cnaan, A.3
-
33
-
-
0030967596
-
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers to localized carcinoma of the prostate
-
Theodorescu D, Broder SR, Boyd JC, Mills SE, Frierson HF Jr. p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers to localized carcinoma of the prostate. J Urol. 1997;158(1):131-7.
-
(1997)
J. Urol.
, vol.158
, Issue.1
, pp. 131-137
-
-
Theodorescu, D.1
Broder, S.R.2
Boyd, J.C.3
Mills, S.E.4
Frierson Jr., H.F.5
-
34
-
-
0032892199
-
Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy
-
Moul JW. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy. Eur Urol. 1999;35(5-6):399-407.
-
(1999)
Eur. Urol.
, vol.35
, Issue.5-6
, pp. 399-407
-
-
Moul, J.W.1
|